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ABSTRACT
oblecdve: a,ganiccationTmnsporterl (OCTIJ,wasknownasthehighlypolymorPhismofPolysPesifictransporter. Thegeneticvafi^bilttyofacTl
might alter the drug response. slch as *ecormin, imatinib, levodop-a ini s-uyaio,.yt iptamine Receptor Antagonist (S'HTRAI drugs' This study
wai ainied to know the variability ofOCTI gene In lndonesian Cancer patlents'
Metbods: The sNps of ocT 1; fs12ZOA337, rs55918055, rs34130495, rs34059508 and amino alid substitution Meth420del were selected'
cenotypes were established using Taqman assays and analysed on ABt 7500 realtime PcR System from APplied Biosystems accotding 
to
manuhcture-s protocol of allelic discrimination.
R€sults: There were no geleti€ variations found in the 202 lndonesian cancer patients according to t]re 4 sNPs included in this snrdy and 
only 1'5%
heterozygous were found in the Met420del. This finding is consistent with the previous studies in ,apannese and chinnese population'
conctusion: The further study ls warranted to do dre sequencing analysis which coutd find the most possible variants in lndollesian 
canc€r paEents'
lr{TRODUCTION
Organic Cadon TmnsporterT fOCIl.), encoded by SLCZZAI' was
loited ln chromosome 6q26 and was known as largest superfamlly
oftransporters nL OCft was maiorly expressed in the liver' it means
tiat the variations ofthis gene would affect the transPort ofthe drug
to the liver {2L Some of t}re mechanism was proposed as the
mechanlsm whlch could explain the role of OCTI polymorphlsms ro
the drug response. The most possible mechanism was probably
related io the drug disposition in the liver which rclennt to the
pharmacodynamics matter 131' For the drugs which are being the
iubstrate of OCTI and are metabolized maiorly by CYP2D6 which
was known highly polymorphisnr, protrably need individualization of
dose administration in different ethniclties.
ln the previous studies of Caucasian subiects, the polymorphisms of
OCII could alter the medormin, imatinib and levodopa response l+ul.
Moreover, the newest s$dy in Caucasian cancer padenB found that
the polymorphisms of Od?I could affect the Patients resPonse to
ondansetrcn and troPlsetron as antlemeuc drugs lrl' Ondansetron
and troplsetmn, the S-Hydroxytriptamine RecePtor Antagonists (5'
HTM), are larown as the antiem€tics used in chemotherapy-induced
nausea vomiting [C!NV]' ln the previous study of lndonesian cancer
subiects, the polymorphtsm s of 5'HT3B gene recePtor, CYP2D6 znd
Mutti Drug Resistancel (i{DRIJ gene were not associated to the
ondansetmn response, However, there were sdll 30% padents
experlenced CINV after treated by hlghly emetogenlc cytostatic
agent lrol. Thus, we should consider the OC?t polymorphisms as the
predictor of drug response, besides considering the subiect
characteristlc.
The previous study in fapannese and Chinese subiects widr diabetes
melitus dismse suggested t}lat new nonsynonymous variants found
could affect the metfomin resPonse' llows€r, t}le nonsynonynou
varlants found in the Caucasian sublecB were not found in their
study trr], Moreover, the previous study in Korean population also
showed the nonsynonymoi(i variants similar to t}le Vietnamese and
Chinese and different variants Fom the Caucasians lrzl.
This study was aimed to find t}re variations of OCTI gene in
lndonesian cancer patients which could b€ related to the s'HTI{A
drug response, since the association between the drug response and
the other genes in the Previous study were not found ltol
MATERTAI.S ITND MCTHODS
SNPs selection
Five SN Ps of oCi' .l were selected from the snrdy of Tzvetkov et al lel;
rs122}8357 (amino acid substitution arginine6l-to-cycteine).
rss5918055 {amino acid substitution cycteineSS-to-arginine},
rs34130495 famino acid substitutlotr Elycine40l'to'serine],
rs34059508 {amino acid substitution glycine46S-to-arginine) and
unknown rs number {amino acid substitution methionine420-to-
deletion methionine). This study has been approved by the ethic
committee of Medicine Faculty, University of Gadiah Mada.
Yogakarta. This study has been Permitted by Faculty of Medicine
Gadiah Mada University, Yognkarb.
DNA collectioD
The deoxyribonucleic acid (DNA) was collected from 202 saliva
samples of lndonesian cancer padents- Sallva was collected at least
one hour after eating meal. The patients were asked to rinse their
mouth before the saliva collection with plain water, After the saliva
was collected in the saliva containet the container was closed and
mix gently for 10 seconds, The container were put in th€ rootn with
ambient temperature,
DNA exFacdon
40Fl DNA purifier was added to 1000 td sallva soludon ln rhe
microcentrifuge tube and vortex the tube for 5 seconds. The tube
ms incubated in the ice for 10 minutes dlen it was centxifuged in
the mom temperature for 5 minutes at 13.000 rPm' 1000 Fl
supernatant was transferred into clean obe and was added by
l000Fl-100% ethanol. The solution was mixed gently for l0 times
and allowed ln the room temperatur€ for 10 mlnutes or until the
DNA was fully preciPitated The supernatant was removed carefully
and 100 pl TE bu$er was added to DNA pell& The solution was
vortexed for 5 seconds t]rcn incubated in tba rum trmP€rature for
l-2 days. DNA was quantified using Nanodrop flsogen, Maarssen,
The Netherlands).
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Allelic Discriminafon
Genotypes were esrablished irsing Taqman essays and analysed on ABI
7500 realtime PCR System from Applied Biosystems (Nieuwerkerk aan
den Ussel, The NethertandsJ accotding to the pmtocol of allelic
dlscrlmtnadorl The solution for alleltc dlscrimina(on were contairRd o{
Taqman Universal PCR Master Mix 2x, (12'50 pl) and sNP gcnotyping
assay {1.25 Fl ) for 96 wells plate in each reactiorL 13.75 d solution was
pipene in m each well of dre plate The plate was perfurmed for pre -
read and amplification running of allelic discrimination The
ampllficadon running used the condldon of: 2 minutes of 30sC and 10
minutes of 95 oC for initial steps and '10 cycles of 15 seconds 95 eC, 't0
cycles of 1 minutes 60 qC for PCR This syst€m is known as dehults times
and tumperan re in ABI 7500 realtime PCR System hom Applied
Bkrsystems. After &e amplification procedures. the post-read ass:ry ms
performed in the machine to get the genotype data
Stadstlcal analysls
The genotype frequencies were assessed for deviations from Hardy
Weinlerg equilibrium and the genotyPe distributlons did not
deviate from Hardy Weinberg equilibrlum.
RESULTS
We did not find the heterozygous and homorygous mutant over the
rs12208357 (amino acid substitution arginine6l'to'cycteine),
rss5918055 (amioo acid subsutution cydeineSS'to-arginine),
rs34130495 famino acid substitution glycine40l'to-serine),
rs34059 508 (amlno acid sub6titution grycine+65-to'arginlnel'
However, there were 1'5% heterozygous found ln unknown rs
number famino acid substitution metiionine4z0-to-deletion
rnethionine). The Table 1 showed the finding of this study'
Table 1: lt shows tbe geuotlryt'g assay rcsult over the ftve SI{ Ps of OCTI
vartants bts!!-?9e
:::;?l:H: wlf$ril i33 ' '
rs34059508 Wild tYPe; GG 100
Met420del Wild ryPe;ATG 98'5
C: cytoslne; T: Thymtne; A: Adenine; G: Guanlne; del: deletion; Met: methlonine
SNP
rs1220835? wlld type; CC
DtscusstoN
This study was aimed to undrstand the variability of oC?l gene
in Indonesian Cancer patients. Our finding was consistent with
the previous study in lapannese and Chinnese' This previous
study found the other new nonsynonymous variants which
assoclated to the metformin response' The Q97K, P117L and
R206C could alter the pharmacokinetic parameters of rnetformin
trtr, [n addition, t]re previous study of Kcrean population, there
were four SNPs involved in their study, such as; F160L, M408V.
P283L and P3.+1L. The first two SNPs did not cause functional
changes, however the remaining SNPs were found as the
decreased functional activity. The allele frequency of P283L
among Korean population, Vietnamese, Chinnese and Caucasians
were similar. However, the allele frequency of P3{1L between
Korean population and Caucasian was significant different lr2l.
This recent study was inconsistent with the previous study in
Caucasian cancer patients, which found the haplotype of similar
SNPs involved and phenotyped the haplotypes as active function
allele and decrease functional alleles. The authors also found the
assoclatlon among the phenotypes s-HTRA drug response te). The
small number of heterozygous in Met420del which is found in
thls current study should be replicated in the next further study
with the larger sample size. Therefore, the next further study is
warranted to find the new nonsynonymous variants in
lndonesian subjects. The decrease functional variants found in
the previous studies in Korean population, lapannese and
Chinese were proposed to explore in lndonesian cancer patients,
coilclustoit
The further study is warranted to do the sequencing analysis
which could lind the most possible variants in lndonesian cancer
patients, To consider the similar SNPs involved in previous
studies of fapannese, Chinnese and Korean population would be
a challenge for the pharmacogenetic studles in lndonesian
population,
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